A new FDA advisory panel meeting, influenced by RFK Jr.'s push for broader access, will weigh the potential benefits and risks of widely promoted peptides. Click the link in bio to read When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions Is BPC157 Legal? WADA, FDA Status, and What You Need to Know The Peptide Craze Part 2: BPC 157, NAD and the Truth Behind the Longevity Molecule Hype FDA Enforcement In 2025: What The Data Reveals So Far